AzTrials
AzTrials

Vascular DiseasesNCT05817487

Effects of COP Exercise and HIIT on Vascular Health in Young Overweight Females

A study testing high-intensity interval training (HIIT) and crossover point(COP) exercise training in people with Vascular Diseases, run by Beijing Sport University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to determine the effects of high-intensity interval training and crossover point exercise training on vascular health in young overweight women. Read more about this study

Who is it for?
Ages 18 to 30 years, women onlyHealthy volunteers can take part
Conditions the study is for
Vascular Diseases
What is being tested?
high-intensity interval training (HIIT) and crossover point(COP) exercise training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteChina
Study dates
18 Feb 2019to 25 Oct 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female, 18-30 years old
  • Body mass index (BMI) < 28 kg/m2 and ≥ 24 kg/m2
  • No exercise habit, and no recent new exercise plan
  • No contraindications to exercise

Who cannot join

  • Participates had an orthopedic or other condition that limited participation in daily exercise
  • Participates had a history of myocardial infarction, stroke, diabetes mellitus, chronic respiratory disease or cancer
  • Participates had smoking or alcohol behavior

Trial locations and contacts

1 site in 1 country.

China1 site
  • Beijing Sport University

    Beijing

Other trials in China

About this study

Official title: Effects of Crossover Point Exercise and High-intensity Interval Training on Vascular Health in Young Overweight Females

The goal of this study is to determine the effects of high-intensity interval training and crossover point exercise training on vascular health in young overweight women.

Read the detailed description

In recent years, improving cardiovascular health through exercise has become a popular research question, however, it is not clear which intensity and modes of exercise bring more benefits. Crossover point(COP) intensity has great medical potential as a personalized exercise intensity that is based on substrate utilization mode, especially in overweight and obese people.On the other hand, several studies have demonstrated that HIIT is an effective method in improving vascular endothelial dysfunction. During our study, we evaluated the vascular health changes in young overweight women who received either COP exercise or HIIT exercise for 10 weeks.

Being tested
high-intensity interval training (HIIT), crossover point(COP) exercise training
Medical subject headings
Vascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • high-intensity interval training (HIIT)Behavioural

    Participants in both the COP and HIIT groups underwent 30 sessions of exercise performed over 10 weeks. The training sessions in the HIIT group involved five high-intensity intervals of 4 minutes each (running or walking on a treadmill) at 85% VO2max interspersed with 3 minutes of low-intensity walking.

  • crossover point(COP) exercise trainingBehavioural

    Participants in both the COP and HIIT groups underwent 30 sessions of exercise performed over 10 weeks. The COP exercise training sessions involved 45 minutes of continuous exercise at the COP on a treadmill.

Study groups in NCT05817487
Study groupRoleWhat they receive
HIIT groupExperimentalNot described
Receives: Behavioral: high-intensity interval training (HIIT)
COP groupExperimentalNot described
Receives: Behavioral: crossover point(COP) exercise training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. brachial-ankle pulse wave velocity (baPWV)

    The change of baPWV before and after intervention

    Measured: 10 weeks

  2. blood pressure

    The change of blood pressure before and after intervention

    Measured: 10 weeks

Secondary outcomes (2)
  1. Interleukin 6 (IL-6)

    The change of IL-6 level before and after intervention

    Measured: 10 weeks

  2. Homocysteine (HCY)

    The change of HCY level before and after intervention

    Measured: 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2023
  2. Study start18 Feb 2019
  3. Primary completion5 Jul 2019
  4. Study completion25 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05817487
Sponsor's protocol ID
EOCPEAHITOVHIYOF
Status last verified
Apr 2023
First submitted
5 Apr 2023
Last updated
18 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing high-intensity interval training (HIIT) and crossover point(COP) exercise training in people with Vascular Diseases, run by Beijing Sport University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

brachial-ankle pulse wave velocity (baPWV) (time frame: 10 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in